http://rdf.ncbi.nlm.nih.gov/pubchem/reference/7942393

Outgoing Links

Predicate Object
contentType Comparative Study|Journal Article|Randomized Controlled Trial|Research Support, Non-U.S. Gov't
endingPage 184
issn 0002-8703
issueIdentifier 1
pageRange 177-184
publicationName American Heart Journal
startingPage 177
bibliographicCitation Olsen MH, Wachtell K, Beevers G, Dahlöf B, Devereux RB, de Faire U, Fyhrquist F, Ibsen H, Kjeldsen SE, Lederballe-Pedersen O, Lindholm LH, Narayan P, Nieminen MS, Omvik P, Oparil S, Wedel H. Prognostic importance of hemoglobin in hypertensive patients with electrocardiographic left ventricular hypertrophy: the Losartan Intervention For End point reduction in hypertension (LIFE) study. Am Heart J. 2009 Jan;157(1):177–84. doi: 10.1016/j.ahj.2008.08.011. PMID: 19081416.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_071b6ee5d4f87818ea0c018bfb88dd68
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_20ebb78cacdb67f1606514cb6bc0e7ac
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_54f077cf050cb5a42ad2debc1af37e0a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0f658fe92148f1fba2768147da42e786
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8a706cd3f0f8541f7cbc1f021e36a4a3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_247ad0b2d453b85b9bfdebc3a81c0f48
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3c8b3608a0c41438ab34659e43d965a2
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_29ac787fa7ab28f01c2d6b9d639a152f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_58b94e3885f188061d905723846fd1ad
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_18f6c9e7a38a10c37faeeef1f541cd95
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_aaa9c2f94802401a2781faafdbed4601
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_db834f06a06565325d7caa698c596f78
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7f2398e146d6307a8edd6387bb47cf08
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b965639c24e01c0ac75fc97771731ce4
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_301de199edce2756c2e7104e18ceafe6
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d6753dbdd59236ed07f4e53cf2156270
date 200901
identifier https://doi.org/10.1016/j.ahj.2008.08.011
https://pubmed.ncbi.nlm.nih.gov/19081416
isPartOf https://portal.issn.org/resource/ISSN/0002-8703
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/398
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Prognostic importance of hemoglobin in hypertensive patients with electrocardiographic left ventricular hypertrophy: The Losartan Intervention For End point reduction in hypertension (LIFE) study
discusses http://id.nlm.nih.gov/mesh/M0010133
http://id.nlm.nih.gov/mesh/M0029400
http://id.nlm.nih.gov/mesh/M0001456
http://id.nlm.nih.gov/mesh/M0001900
http://id.nlm.nih.gov/mesh/M0000495
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D000959Q000627
http://id.nlm.nih.gov/mesh/D006973Q000097
http://id.nlm.nih.gov/mesh/D001262Q000627
http://id.nlm.nih.gov/mesh/D017379Q000150
http://id.nlm.nih.gov/mesh/D006973Q000188
http://id.nlm.nih.gov/mesh/D000319Q000627
http://id.nlm.nih.gov/mesh/D019808Q000627
http://id.nlm.nih.gov/mesh/D006454Q000032
hasSubjectTerm http://id.nlm.nih.gov/mesh/D006973Q000401
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D006973Q000150
http://id.nlm.nih.gov/mesh/D011379
http://id.nlm.nih.gov/mesh/D017379Q000175
http://id.nlm.nih.gov/mesh/D000369
http://id.nlm.nih.gov/mesh/D000368
http://id.nlm.nih.gov/mesh/D008875
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D004562
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10602
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3961
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2249
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8102
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10017
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8564

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128961263
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128585206

Total number of triples: 65.